Schedule 13G ownership disclosure
ETERNA THERAPEUTICS INC
Security class unavailable · CUSIP: 114082209
Event date: 2023-07-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-23-075157
- Form type
- SC 13G
- Filer
- Ernexa Therapeutics Inc.
- CIK
- CIK 748592
- Filed
- Sep 08, 2023
- Reporting period
- Jul 06, 2023
- Description
- Schedule 13G beneficial ownership